Abstract:This article presented the metabolic reprogramming of tumor cells to adapt to their microenvironment distinct from normal cells. And this study reviewed the driving factors of metabolic reprogramming, the specific metabolic pathway changes affected, and the related treatment options, in order to provide some suggestions for future tumor treatment. Cancer cells characterized by uncontrolled growth and proliferation require altered metabolic processes to maintain this characteristic. Metabolic reprogramming is a process mediated by various factors, including oncogenes, tumor suppressor genes, changes in growth factors, and tumor–host cell interactions, which help to meet the needs of cancer cell anabolism and promote tumor development. Metabolic reprogramming in tumor cells is dynamically variable, depending on the tumor type and microenvironment, and reprogramming involves multiple metabolic pathways. These metabolic pathways have complex mechanisms and involve the coordination of various signaling molecules, proteins, and enzymes, which increases the resistance of tumor cells to traditional antitumor therapies. With the development of cancer therapies, metabolic reprogramming has been recognized as a new therapeutic target for metabolic changes in tumor cells. Therefore, understanding how multiple metabolic pathways in cancer cells change can provide a reference for the development of new therapies for tumor treatment. Here, we systemically reviewed the metabolic changes and their alteration factors, together with the current tumor regulation treatments and other possible treatments that are still under investigation. Continuous efforts are needed to further explore the mechanism of cancer metabolism reprogramming and corresponding metabolic treatments.

Crosstalk between metabolic remodeling and epigenetic reprogramming: A new perspective on pancreatic cancer

Emerging mechanisms and promising approaches in pancreatic cancer metabolism

Reprogramming of Amino Acid Metabolism in Pancreatic Cancer: Recent Advances and Therapeutic Strategies

Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential

Pancreatic cancer and fibrosis: Targeting metabolic reprogramming and crosstalk of cancer-associated fibroblasts in the tumor microenvironment

Crosstalk Between Metabolic and Epigenetic Modifications During Cell Carcinogenesis

The role of metabolic reprogramming in pancreatic cancer chemoresistance

Metabolic landscape of the healthy pancreas and pancreatic tumor microenvironment

An Overview of Epigenetic Methylation in Pancreatic Cancer Progression

Glucose metabolism and tumour microenvironment in pancreatic cancer: A key link in cancer progression

The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives

Interplay Among Metabolism, Epigenetic Modifications, and Gene Expression in Cancer

The cancer metabolic reprogramming and immune response

Metabolic reprogramming in cancer: Mechanisms and therapeutics

Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches

Crosstalk between the Tumor Microenvironment and Immune System in Pancreatic Ductal Adenocarcinoma: Potential Targets for New Therapeutic Approaches

Association between Metabolic Reprogramming and Immune Regulation in Digestive Tract Tumors

Connections between metabolism and epigenetics: mechanisms and novel anti-cancer strategy

Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer

Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression

Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution